The stock of Walgreens Boots Alliance Inc. (NASDAQ:WBA) last traded at $31.35, down -0.48% from the previous session.
WBA stock price is now -7.73% away from the 50-day moving average and -13.39% away from the 200-day moving average. The market capitalization of the company currently stands at $27.14B.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
With the price target of $45, Loop Capital recently initiated with Buy rating for Walgreens Boots Alliance Inc. (NASDAQ: WBA)., while ‘Cowen’ rates the stock as ‘Outperform’.
In other news, Walgreens Boots Alliance, Inc., 10% Owner sold 292,792 shares of the company’s stock on May 11. The stock was sold for $50,000,090 at an average price of $170.77. Upon completion of the transaction, the 10% Owner now directly owns 33,366,388 shares in the company, valued at $1.05 billion. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 29, CEO BREWER ROSALIND G bought 10,000 shares of the business’s stock. A total of $339,510 was incurred on buying the stock at an average price of $33.95. This leaves the insider owning 369,945 shares of the company worth $11.6 million. Insiders disposed of 157,909 shares of company stock worth roughly $4.95 million over the past 1 year. A total of 0.30% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in WBA stock. A new stake in Walgreens Boots Alliance Inc. shares was purchased by COBALT CAPITAL MANAGEMENT, INC. during the first quarter worth $5,643,000. BAYESIAN CAPITAL MANAGEMENT, LP invested $4,191,000 in shares of WBA during the first quarter. In the first quarter, AIGEN INVESTMENT MANAGEMENT, LP acquired a new stake in Walgreens Boots Alliance Inc. valued at approximately $4,123,000. INVENOMIC CAPITAL MANAGEMENT LP acquired a new stake in WBA for approximately $4,100,000. WORLDQUANT MILLENNIUM ADVISORS LLC purchased a new stake in WBA valued at around $4,004,000 in the second quarter. In total, there are 1,647 active investors with 59.80% ownership of the company’s stock.
During the past 12 months, Walgreens Boots Alliance Inc. has had a low of $30.39 and a high of $44.96. As of last week, the company has a debt-to-equity ratio of 0.66, a current ratio of 0.60, and a quick ratio of 0.30. The fifty day moving average price for WBA is $33.90 and a two-hundred day moving average price translates $36.16 for the stock.
The latest earnings results from Walgreens Boots Alliance Inc. (NASDAQ: WBA) was released for Feb, 2023. According to the Pharmaceutical Retailers Company, earnings per share came in at $1.16, beating analysts’ expectations of $1.1 by 0.06. This compares to $0.93 EPS in the same period last year. The net profit margin was -2.40% and return on equity was -13.50% for WBA. The company reported revenue of $34.86 billion for the quarter, compared to $33.76 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 3.28 percent. For the current quarter, analysts expect WBA to generate $34.18B in revenue.
Moreover, the firm recently paid out its quarterly dividend on 06/12/2023. Investors who held shares on 05/19/2023 were paid a $0.48 dividend. On an annualized basis, this represents a $1.92 dividend and a 6.12% percent yield. There was an ex-dividend date of 05/18/2023 for this dividend. In terms of dividend payout ratio, WBA is presently at 38.21%.
Walgreens Boots Alliance Inc.(WBA) Company Profile
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. The company operates under the Walgreens and Duane Reade brands in the United States. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. The company operates retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
